Reetu Mukherji, MD| Gastrointestinal Medical Oncology, Hematology and Oncology | MedStar Health
About me
Reetu Mukherji, MD, is a fellowship-trained medical oncologist. She specializes in management of gastrointestinal malignancies, including esophagus, stomach, small bowel, colon, rectum, anal, pancreatic, and hepatobiliary cancers. Dr. Mukherji leads the medical oncology department’s clinical and research focus on upper gastrointestinal malignancies, including esophageal and gastric cancers.
She earned her medical degree from Temple University School of Medicine and completed her residency at Thomas Jefferson University Hospital, both of which are located in Philadelphia. Dr. Mukherji completed a fellowship in hematology/oncology at MedStar Georgetown University Hospital.
Dr. Mukherji has published in several peer-reviewed journals, including Current Treatment Options in Oncology and Journal of Clinical Oncology, on the role of immunotherapies, applications of prognostic genomic biomarkers, and applications of liquid biopsies in the management of patients with gastrointestinal malignancies. She has also designed investigator-initiated clinical trials studying emerging blood-based biomarkers like circulating tumor DNA and testing novel therapies across gastrointestinal cancers. Her research includes collaboration with basic scientists to study circulating tumor cells from liquid biopsies.
She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Medical Association.
About MedStar Georgetown Cancer Institute
MedStar Georgetown is part of the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.
Dr. Mukherji’s philosophy of care
Dr. Mukherji is committed to approaching each patient comprehensively and with respect. She understands a cancer diagnosis is life-changing for patients and values educating them on their complex disease and management strategies in order to make informed decisions together in their best interest. She strongly believes in the value of working collaboratively with patients, their support systems, and multi-disciplinary teams to deliver the highest level of care and support through their cancer diagnosis.
Clinical areas of focus
- Antineoplastic Injection
- Blood Clotting Disorder Treatment
- Colectomy
- Endoscopic Mucosal Resection
- Gastric Cancer
- Low Anterior Resection
- Rectal Cancer
- Small Intestine Cancer
Conditions and procedures
Conditions I treat
- Abdominal Cancer
- Abnormal Tumor Markers
- Anal Cancer
- Anemia
- Appendiceal Cancer
- Appendix Cancer
- Ascites
- Basal Cell Carcinoma Of Skin
- Benign Neoplasm Of Kidney
- Benign Neoplasm Of Skin
- Benign Neoplasm Of Urinary Organs
- Bile Duct Cancer
- Bladder Cancer
- Bladder Carcinoma
- Bleeding Disorders
- Breast Cancer
- Cancer Of The Appendix
- Cervical Cancer
- Clotting Disorders
- Colon Cancer
- Colorectal Malignancy
- Cyclic Vomiting Syndrome
- Diseases Of Blood And Blood
- Disorders Of Carbohydrate Metabolism
- Disorders Of Mineral Metabolism
- Disorders Of White Blood Cells
- Duodenal Cancer
- Duodenum Cancer
- Esophageal Cancer
- Family History Of Malignant Neoplasm
- Gallbladder Cancer
- Gastric Adenocarcinoma
- Gastric Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Hematological Disorder
- Intrahepatic Bile Ducts Cancer
- Larynx Cancer
- Leukopenia
- Liver Cancer
- Lung Cancer
- Malignant Neoplasm
- Malignant Neoplasm Of Bladder
- Malignant Neoplasm Of Cervix Uteri
- Malignant Neoplasm Of Connective And Soft Tissue
- Malignant Neoplasm Of Lymph Nodes
- Malignant Neoplasm Of Ovary
- Malignant Neoplasm Of Retroperitoneum
- Malignant Neuroendocrine Tumors
- Melanoma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Bone Disease
- Metastatic Cancer
- Multiple Myeloma
- Myeloproliferative Neoplasms
- Neoplasm Analysis
- Neoplasm Of Uncertain Behavior
- Neutropenia
- Noninfective Gastroenteritis
- Ovarian Cancer
- Pancreas Cancer
- Papillary Carcinoma Of Breast
- Pediatric Cancer Survivorship
- Pericardium Diseases
- Rectal Cancer
- Sickle Cell Disease
- Small Intestine Cancer
- Stomach Cancer
- Thrombocytopenia
- Transitional Cell Carcinoma
- Transplanted Organ And Tissue Status
- Upper Gi Cancer
- Venous Embolism
- Vitamin Deficiency Anemia
- Wilms Tumor
Procedures I perform
- Abdominal Wall Tumor Resection
- Adjuvant Hormone Therapy
- Anemia Management
- Antiangiogenic Therapy
- Antineoplastic Injection
- Anxiety Management
- Blood Banking
- Blood Clotting Disorder Treatment
- Blood Transfusion
- Bone Cancer Staging
- Bone Marrow Failure Syndrome Treatment
- Brachytherapy
- Cancer Psychological Counseling
- Cancer Rehabilitation
- Cancer Risk Assessment
- Chemotherapy Administration
- Cholecystectomy
- Clinical Trials
- Coagulopathy Management
- Cold Laser Therapy
- Colectomy
- Cushing Syndrome Management
- Endocrinology Care
- Endoscopic Clip Placement
- Endoscopic Mucosal Resection
- Fatigue Management
- Gastrectomy
- Gastric Stenting
- Gastrointestinal Cancer Prevention
- Genomic Testing For Cancer
- Gynecological Cancer Screening
- Hematology Consultation
- Hepatectomy
- Hepatic Artery Infusion
- Ileostomy
- Iliac Bone Marrow Extraction
- Iliopopliteal Bypass
- Immune Cell Therapy Administration
- Immunotherapy
- Inpatient Palliative Care
- Internal Jugular Central Line Placement
- Internal Radiation Therapy
- Intravenous (IV) Fluids
- Laparoscopic Revision Of Gastric Restrictive Procedure
- Leukemia Management
- Liver Tumor Ablation
- Low Anterior Resection
- Lymph Node Biopsy
- Lymphoma Management
- Mesenchymal Stem Cell Transplant
- Methylation Profiling
- Minimally Invasive Surgery
- Neoadjuvant Therapy
- Nutrition Counseling
- Oncology Consultation
- Pancreatectomy
- Pathology Consultation
- Percutaneous Tumor Chemoembolization
- Perianal Surgery
- Peripheral Blood Stem Cell Transplantation
- Radiation Therapy
- Removal Of Central Venous Access Device
- Sickle Cell Anemia Treatment
- Thrombophilia Management
- Tobramycin Administration
- Tumor Immunohistochemistry
- Tumor Resection
- Venous Access Device Irrigation
- Venous Blood Collection
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Private Health Care Systems (PPO)
- Medicare FFS
- United Healthcare Select HMO-EPO/NPP Cardiac Global
- IH-POS Plus
- AmeriHealth Caritas DC Healthcare Alliance
- Kaiser Permanente Medicare Plus
- IH-Network Only Plus
- IH-POS
- Cigna Alliance Medicare (HMO)
- Aetna Classic 5000PD
- UnitedHealthcare and AARP Medicare Complete Plans
- United Healthcare Choice Plus Cardiac Global
- TRICARE for Life East
- CareFirst (NCA) Indemnity
- Kaiser Maryland Medicaid MCO
- Anthem BCBS of VA HealthKeepers (HMO)
- MultiPlan, Inc
- Erickson Advantage Plans
- Anthem Federal Employee Program Basic
- CIGNA PPO
- Magellan Complete Care of VA - VA Medicaid MCO
- BCBS Out-of-State Medicare Plans (Blue Advantage)
- United HealthCare Community Plan - Maryland Health Choice Program
- United Healthcare Community Plan - VA Medicaid MCO
- HighMark
- AMERIVANTAGE/Amerigroup Community Care
- CareFirst BlueCross BlueShield Advantage Core/Enhanced
- HealthyBlue PPO
- Aetna Signature Administrator PPO/TPA
- UnitedHealthcare Individual Exchange Plans
- Healthy Blue (HMO, POS)
- Cigna True Choice Plus Medicare (PPO)
- CareFirst Maryland Point of Service Plan
- Kaiser Permanente Medicare Advantage Signature and Select
- United Healthcare Navigate Cardiac Global
- Amerigroup DC Alliance
- Humana Gold Plus HMO
- DC/MD SHOP QHP Small Business Plans
- CareFirst Group Medicare Advantage
- Aetna Advantage 6350PD
- OA Plus
- Maryland Physicians Care MCO
- Health Services for Children with Special Needs
- Aetna Advantage 6350
- IH-HMO
- Anthem Federal Employee Program Standard
- CIGNA PPO Plus
- CIGNA Indemnity
- Aetna Open Choice (PPO)
- MD IPA (HMO) & MD IPA Preferred Cardiac Global
- Coventry Health Care National Network PPO
- Kaiser Permanente HMO Plus and DHMO Plus Member
- IH-Indemnity
- Johns Hopkins Advantage MD HMO
- Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
- Lasso Healthcare - Medicare Medical Savings Account
- Cigna True Choice Medicare (PPO)
- First Health PPO
- Optimum Choice Preferred (POS)
- UHC Group Medicare Advantage Plans (HMO, POS, PPO)
- TRICARE East Prime
- Employee Health Plan
- Anthem BCBS of VA Key Care POS/PPO/Indemnity
- Aetna Basic
- Jai Medical Systems - Maryland Health Choice
- Choice POS II Open Access
- Navigate
- Mamsi Life & Health (Indem./PPO)
- CareFirst Blue Preferred PPO
- Anthem BCBS Medi Blue Dual Adv
- Blue Choice Advantage
- IH-Open EPO Plus
- Private Fee-for-Service Plans (PFFS)
- HumanaChoice Honor's plan PPO
- IH-Open HMO Option
- IH-Open POS Plus
- Aetna Managed Choice (POS)
- Amerigroup DC Healthy Families
- IH-Open HMO
- POS OA
- Aetna Medicare Advantage PFFS Plan
- CareFirst Blue Choice Opt Out Plus Open Access (POS)
- MedStar Family Choice - Maryland Health Choice
- CareFirst Community Health Plan of MD
- CIGNA POS/Network POS
- CareFirst BlueChoice HMO
- Anthem BCBS Medi Blue Plus
- Medicare Direct
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- Aetna HMO
- Aetna Medicare Advantage HMO & PPO Plans
- IH-PPO
- CareFirst MedStar Select PPO
- CareFirst MedStar PPO
- United Healthcare Options (PPO)
- CIGNA HMO & Network (HMO)
- M.D. IPA (HMO)
- Kaiser Permaenete Signature - Added Choice Cardiac Global
- Police and Fire Clinic
- Sentara Health
- Veterans Affairs Community Care Network
- CareFirst Federal Employee Program (Std. & Basic PPO)
- Aetna Quality Point of Service (POS)
- Aetna Worker's Compensation Network
- HUMANA/Choice Care Medicare Plans (Choice, Gold Choice)
- Uniformed Services Family Health Plan
- Kaiser Permanente Signature
- TriWest Healthcare Alliance
- TRICARE East Select
- Beech Street PPO
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- WellPoint Maryland - Maryland Health Choice
- Kaiser Permanente Select Cardiac Global
- First Health PPO
- Anthem BCBS of VA HealthKeepers (POS & POS OA)
- MedStar Family Choice DC Healthy Families
- IH-EPO Plus
- BlueChoice Open Access
- Optimum Choice
- HumanaChoice PPO
- Humana Medicare Advantage - PPO
- United Student Resources
- OCI Direct (HMO)
- CareFirst NASCO
- Priority Partners - Maryland Health Choice
- Kaiser Permanente Select
- United Healthcare Choice Plus
- MedStar Family Choice - Maryland Health Choice
- UnitedHealthcare Medicare Advantage DSNP District of Columbia
- Aetna Traditional Choice (PPO)
- Alterwood Advanatge HMO & DSNP Plans
- BCBS of Michigan (BCN Advantage,Security Blue, Freedom, Medicare PLUS Blue Group PPO)
- Aetna Elect Choice/ Open Access (POS)
- Aetna Managed Choice Open Access (POS)
- Choice POS
- Cigna TotalCare (HMO D-SNP)
- Aetna Classic 3500
- Humana Medicare Advantage - HMO Open Access
- Anthem BCBS Medi Blue SNP
- Coventry of Delaware HMO/PPO
- Choice POS II
- Choice Care Network/HUMANA (PPO)
- United Medicare Private Fee-for-Service (PFFS) plans
- CIGNA EPO
- MedStar Family Choice DC Healthcare Alliance
- IH-Open POS II
- Kaiser Permanente Flexible Choice 3-tier POS
- Johns Hopkins Advantage MD PLUS PPO
- Aetna Better Health of MD
- CareFirst Administrators
- CIGNA Connect EPO
- AmeriHealth Caritas DC Healthy Families
- United Healthcare Select HMO - EPO/NPP
- Kaiser Permanente Signature - Added Choice
- United Healthcare Select Plus (POS)
- UHC Passport
- Optima Family Care MCO - VA Medicaid MCO
- Aetna Premier 200PD
- Cigna Achieve Medicare (HMO C-SNP)
- Aetna Better Health of VA
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- Geisinger Medicare Advantage
- IH-Open Network Only Plus
- CareFirst FEP Blue Focus
- Choice Fund PPO
- Aetna VA Exchange
- MedStar Family Choice DC Healthcare Alliance
- Optimum Choice & Optimum Choice Preferred (POS) Cardiac Global
- Select HMO/HealthFund/Health Network
- CareFirst Maryland Indemnity or PPO
- Johns Hopkins Advantage MD PPO
- CIGNA HMO Open Access
- United Healthcare Choice Cardiac Global
- Advantra Platinum (PPO)
- UnitedHealthcare Medicare Adv. Special Needs Plans
- Kaiser Permanente Flexible Choice POS Cardiac Global
- M.D. IPA Preferred (POS)
- Aetna Student Health Insurance
- Cigna Preferred Medicare (HMO)
- Core Essential (HMO)
- CareFirst Blue Choice Opt Out Open Access
- Network OA
- UnitedHealthcare Individual Exchange Plans
- Coventry Health Care of Virginia
- Options PPO Cardiac Global
- Great-West Healthcare POS/CIGNA
- NYC Medicare Advantage Plus
- CareFirst Dual Prime HMO-SNP
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- Mamsi Life & Health (Indem./PPO)
- Anthem BCBS of VA HealthKeepers Plus
- Tricare Reserve Select
- Mamsi Life & Health (Indem./PPO) Cardiac Global
- Aetna Classic 5000
- Kaiser Permanente Select - Added Choice
- Medicare Advantage - Advantra Value (PPO)
- CareFirst Blue Card Program
- Aetna Advantage 5750
- CareFirst EPO
- CIGNA SureFit (HMO)
- United Healthcare Choice
Videos
Education
Board Certification: American Board of Internal Medicine, Internal Medicine
Fellowship: MedStar Georgetown University Medical Center (2022)
Residency: Sidney Kimmel Medical College (2019)
Medical School: Temple University School of Medicine (2016)
Hospital affiliations
News and publications
PEER-REVIEWED MANUSCRIPTS:
- Mukherji R, Debnath D, Hartley M, Noel M. The Role of Immunotherapy in Pancreatic Cancer. Current Oncology. 2022; 29(10):6865-6892. doi: 10.3390/curroncol29100541
- Mukherji R, Yin C, Hammed R, Alqahtani A, Kulsekaran M, He A, Weinberg B, Marshall J, Hartley M, Noel M. The Current State of Molecular Profiling in Gastrointestinal Malignancies. Biology Direct. 2022; 18:15. doi.org/10.1186/s13062-022-00322-0
- Mukherji R, Alqahtani A, Winters H, Weinberg B. Use of Circulating Tumor DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers. touchREVIEWS in Oncology & Haematology. 2022; 18(1): Online ahead of journal publication.
- Mukherji R, Weinberg B, Pedersen K. Immunotherapy for Colorectal Cancer. Hematology/Oncology Clinics of Northern America. 2022; 36(3): 603-626. doi 10.1016/j.hoc.2022.02.010.
- Mukherji R, Marshall J. Lessons Learned in Managing Patients with Colorectal Cancer During the Covid-19 Pandemic. Current Treatment Options in Oncology. 2021; 22(10):93. doi: 10.1007/s11864-021-00888-3.
- Mukherji R, Weinberg B. The Gut Microbiome and Potential Implications for Early-Onset Colorectal Cancer. Colorectal Cancer. 2020; 9(3). doi: 10.2217/crc-2020-0007.
- Mukherji R, Marshall J, Seeber A. Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers (Basel). 2020; 12(8): 2001. doi: 10.3390/cancers12082001
- Johnson W, Mukherji R, Kartan S, Nikbakht N, Porcu P, Alpdogan O. Allogenic Hematopoietic Stem Cell Transplantation in Advanced Stage Mycosis Fungoides and Sezary Syndrome: A Concise Review. Chinese Clinical Oncology. 2019; 8(1):12. doi 10.21037/cco.2018.10.03.
- Jain R, Savage M, Forman AD, Mukherji R, Hall, M. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling. Journal of the National Comprehensive Cancer Network. 2016;14(6): 795-806. doi:10.6004/jnccn.2016.0080.
- Mukherji R, Yin C, Weinberg B, Alqahtani A, Hameed R, Barcellos A, Connole M, Pereigut C, Fortuin J, Marshall J. Continuous maintenance (Maint) capecitabine (Cape) dosing for colorectal (CRC) and pancreatic cancers (PC): A single-institution, retrospective, real-world study. Poster accepted for presentation at 2023 GI ASCO; Jan 19-21, 2023; San Francisco, California, USA.
- Mukherji R, Suguru S, Xiao J, Geng X, Wang H, Noel M, He A, Weinberg B, Marshall J, Agarwal S. Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic cancer (PC). Poster accepted for presentation at 2023 GI ASCO; Jan 19-21, 2023; San Francisco, California, USA.
- Mukherji R, Boudriga A, Isenstein H, Marshall J. Establishing the feasibility of a patient-engagement tool to improve outpatient symptom management and dosing of patients on regorafenib. Poster presented at 2022 ASCO Quality Care Symposium; Oct 1, 2022; Chicago, IL, USA.
- Debnath D, Nair N, Mukherji R, Marshall J. A rare case of recurrent metastatic neuroendocrine adenoma of the middle ear. Poster presented at 2022 DC American College of Physicians Scientific Meeting; May 21, 2022; Washington, District of Columbia, USA.
- Alqahtani A, Alloghbi A, Yin C, Mukherji R, Weinberg B. Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Poster presented at 2022 GI ASCO; Jan 20-22, 2022; San Francisco, California, USA.
- Bauml J, Mick R, McCoach C, Weiss J, Marrone K, Nieva J, Villaruz L, Levy B, Moreno R, Mukherji R, Sun F, Schwartzman W, Shaverdashvili K, Wang X, Shah M, Woodley J, Miller N, Succe C, Ullah T, Lovly C, Doebele R, Iams W, Horn L, Dowell J, Liu G, Leighl N, Patil T, Liu S, Velcheti V, Aisner D, Camidge R. Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study. Poster presented at: 2020 World Conference on Lung Cancer; Jan 28-31, 2021; Singapore.
- Shah R, Ellingsen H, Halloran M, Mukherji R, Kloo J, Lev Y. Get With the Rhythm- Telemetry Education in Internal Medicine Residency. Poster presented at: The Annual House Staff Quality Improvement and Patient Safety Poster Session; June 2018; Philadelphia, PA, USA.
- Kaczmar J, Gustafom K, Wong Y, Mukherji R, Minniti C, Sandilya V, Sprandio J, Chertock Y, Hart C, Hall M. Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC). Poster Presented at: 2016 ASCO Annual Meeting; June 3-7; Chicago, IL, USA.
- Dave H, Mukherji R, Johnson S, Williams D, Jacobsohn D, Bollard C, Williams K. Voriconazole Levels Indicate That Pediatric Prophylaxis Dosing May be Insufficient. Poster Presented at: Biology of Blood and Marrow Transplantation ASPHO 2015 Annual Meeting; May 6-8, 2015; Washington, D.C.
- Gautam J, Gevaria A, Mukherji R, Bolton K. T Cell Epitope Spreading In Experimental Autoimmune Glomerulonephritis (EAG) In Rats. Poster presented at: ASN Kidney Week 2013 Annual Meeting; Nov 5-10, 2013; Atlanta, GA.